These findings provide evidence for the involvement of Aβ42 in alterations in nucleolar tau in cultured cells and in a corresponding dysfunction of protein synthesis machinery, which has been associated with mild cognitive impairment (MCI) and early stages of AD. The gene discussed is MAPT; the disease is Cognitive impairment.